These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [A case of chronic myeloid leukemia in an infant, treated with urethane]. SCARIZZA PM Minerva Pediatr; 1950 Jun; 2(6):278-84. PubMed ID: 15438884 [No Abstract] [Full Text] [Related]
7. Urethane in the treatment of chronic myelogenous leukemia. CRONE RL; ULRICH DM Bull U S Army Med Dep; 1948 Aug; 8(8):636-40. PubMed ID: 18876396 [No Abstract] [Full Text] [Related]
8. Chronic myelogenous leukemia treated with urethane; report of a case. CLAUDY WD Med Ann Dist Columbia; 1949 Apr; 18(4):185-7. PubMed ID: 18116360 [No Abstract] [Full Text] [Related]
9. [The pathologic anatomy of chronic myelosis as effected by urethane therapy]. MASSHOFF W; HEINZEL W Dtsch Med Wochenschr; 1950 Dec; 75(51):1722-6. PubMed ID: 14802153 [No Abstract] [Full Text] [Related]
10. [Multiple successive and simultaneous treatment in a case of chronic myeloid leukemia]. CAPPELLO F Prog Med (Napoli); 1951 Apr; 7(8):217. PubMed ID: 14844498 [No Abstract] [Full Text] [Related]
11. [Chronic myeloid leukemia treated with urethanes, medical clinical note]. D'ORS JP Med Cir Guerra; 1949; 11(11-12):530-2. PubMed ID: 15409041 [No Abstract] [Full Text] [Related]
12. [Critical observations on urethane therapy of chronic myelosis during the last 5 years]. MICHEL H Munch Med Wochenschr; 1952 Jan; 94(3):117-23. PubMed ID: 14919426 [No Abstract] [Full Text] [Related]
13. [A case of chronic myeloid leukemia treated with ehtylurethane; two cases of malignant granuloma treated with chloramine]. MASUELLI L Minerva Med; 1949 Sep; 40(44 Pt 2):297-9. PubMed ID: 15392158 [No Abstract] [Full Text] [Related]
14. Ethyl carbamate (urethane) in the treatment of chronic myelocytic leukemia; results of a three-year study. COOPER T; WATKINS CH Med Clin North Am; 1950 Jul; 34(4):1205-15. PubMed ID: 15429439 [No Abstract] [Full Text] [Related]
15. [Preliminary results of combined urethane, nitrogen mustard and Delbet's vaccine therapy of chronic myelocytic leukemias]. SZREDER W; MIGDALSKA Z Pol Tyg Lek (Wars); 1951 May; 6(18-19):620-4. PubMed ID: 14875527 [No Abstract] [Full Text] [Related]
16. Chronic myeloid leukaemia. I. Some observations on chronic myeloid leukaemia. GALTON DA Br J Radiol; 1953 Jun; 26(306):285-90. PubMed ID: 13051542 [No Abstract] [Full Text] [Related]
17. Histamine and histaminase in chronic myeloid leukaemia of man: histamine in the blood of chronic myeloid leukaemia. THIERSCH JB Aust J Exp Biol Med Sci; 1947 Mar; 25():73-7. PubMed ID: 20266429 [No Abstract] [Full Text] [Related]
18. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia. Melo JV; Goldman JM Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550 [TBL] [Abstract][Full Text] [Related]
19. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells. Withey JM; Marley SB; Kaeda J; Harvey AJ; Crompton MR; Gordon MY Br J Haematol; 2005 May; 129(3):377-80. PubMed ID: 15842662 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of leukaemia. I. Myleran in the treatment of chronic myeloid leukaemia. GREIG HB S Afr Med J; 1956 Apr; 30(15):357-60. PubMed ID: 13324391 [No Abstract] [Full Text] [Related] [Next] [New Search]